Noffsinger A E, Belli J M, Fogt F, Fischer J, Goldman H, Fenoglio-Preiser C M
Department of Pathology, University of Cincinnati College of Medicine, OH 45267-0529, USA.
Hum Pathol. 1999 Jan;30(1):8-12. doi: 10.1016/s0046-8177(99)90293-9.
Recently, a polymorphism in the hMSH2 DNA mismatch repair gene has been associated with the development of dysplasia in ulcerative colitis (UC) patients. This polymorphism is of interest because DNA mismatch repair defects result in alterations in microsatellite stability. The current study was designed to determine whether this hMSH2 polymorphism associates with the development of microsatellite instability and dysplasia in UC patients. The hMSH2 genotype of 96 UC patients was determined by direct DNA sequencing. In addition, we examined 363 samples of colonic mucosa from 93 of these UC patients for microsatellite mutation by polymerase chain reaction (PCR) at eight loci. Three cases had insufficient DNA for microsatellite instability studies. The hMSH2 polymorphism was identified in 13 of the 96 patients examined (13.5%). The polymorphism was observed in 7 of 46 patients with dysplasia (15.2%), and in 6 of 50 patients without dysplasia (12.0%). Microsatellite instability was identified in 35 tissue samples (25 regenerative, one indefinite for dysplasia, eight dysplasias, and one invasive carcinoma) from 26 patients. Two patients with microsatellite instability had the hMSH2 alteration. The 11 remaining patients had the hMSH2 polymorphism, but no evidence of microsatellite mutations with any of the markers tested. We were unable to confirm the previously reported findings that the specific germline hMSH2 alteration represents a marker for increased risk of dysplasia in patients with UC, nor is it responsible for the development of microsatellite instability in these patients.
最近,hMSH2 DNA错配修复基因中的一种多态性已被证实与溃疡性结肠炎(UC)患者发育异常的发生有关。这种多态性备受关注,因为DNA错配修复缺陷会导致微卫星稳定性改变。本研究旨在确定这种hMSH2多态性是否与UC患者微卫星不稳定性和发育异常的发生相关。通过直接DNA测序确定了96例UC患者的hMSH2基因型。此外,我们对其中93例UC患者的363份结肠黏膜样本进行了检测,通过聚合酶链反应(PCR)检测了8个位点的微卫星突变。有3例样本DNA量不足,无法进行微卫星不稳定性研究。在所检测的96例患者中,有13例(13.5%)发现了hMSH2多态性。在46例发育异常患者中有7例(15.2%)观察到这种多态性,在50例无发育异常的患者中有6例(12.0%)观察到这种多态性。在26例患者的35份组织样本(25份再生组织、1份发育异常情况不确定、8份发育异常组织和1份浸润性癌组织)中发现了微卫星不稳定性。2例微卫星不稳定性患者存在hMSH2改变。其余11例患者有hMSH2多态性,但在所检测的任何标记中均未发现微卫星突变的证据。我们无法证实先前报道的结果,即特定的种系hMSH2改变是UC患者发育异常风险增加的标志物,也不能证明其与这些患者微卫星不稳定性的发生有关。